Masimo (NASDAQ:MASI) supports medical monitoring innovation as nasdaq composite discussions include healthcare technology ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
Masimo has received a go-ahead from its board of directors to carve out its consumer-focused businesses, slimming itself down to focus on professional patient monitoring devices and telehealth ...
Zacks.com on MSN
Here's Why You Should Retain Masimo Stock in Your Portfolio Now
MASI's strong Q3 2025 results, FDA clearance and partnerships fuel growth hopes, but SET dependence and reimbursement risks ...
(RTTNews) - Masimo Corporation (MASI) Monday said it received clearance from the Food and Drug Administration (FDA) for its over-the-counter monitoring system Stork for babies up to 18 months. Stork ...
Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...
Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback